Cita APA

Stein, R., Gupta, P., Chen, X., Cardillo, T. M., Furman, R. R., Chen, S., . . . Goldenberg, D. M. (2010). Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. American Society of Hematology.

Citación estilo Chicago

Stein, Rhona, Pankaj Gupta, Xiaochuan Chen, Thomas M. Cardillo, Richard R. Furman, Susan Chen, Chien-Hsing Chang, y David M. Goldenberg. Therapy of B-cell Malignancies By Anti–HLA-DR Humanized Monoclonal Antibody, IMMU-114, Is Mediated Through Hyperactivation of ERK and JNK MAP Kinase Signaling Pathways. American Society of Hematology, 2010.

Cita MLA

Stein, Rhona, et al. Therapy of B-cell Malignancies By Anti–HLA-DR Humanized Monoclonal Antibody, IMMU-114, Is Mediated Through Hyperactivation of ERK and JNK MAP Kinase Signaling Pathways. American Society of Hematology, 2010.